We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$45.8M
Cap. Flow
+$213M
Cap. Flow %
10.7%
Top 10 Hldgs %
56.29%
Holding
416
New
63
Increased
249
Reduced
78
Closed
21

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$39.6M
2
NVDA icon
NVIDIA
NVDA
+$38M
3
MSFT icon
Microsoft
MSFT
+$36.6M
4
AMZN icon
Amazon
AMZN
+$12.2M
5
YUMC icon
Yum China
YUMC
+$10.6M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$45M
2
FUTU icon
Futu Holdings
FUTU
+$16.1M
3
TSM icon
TSMC
TSM
+$13.2M
4
AMAT icon
Applied Materials
AMAT
+$7.81M
5
TME icon
Tencent Music
TME
+$4.18M

Sector Composition

Rank Sector Weight
1 Technology 40.04%
2 Consumer Discretionary 27.82%
3 Communication Services 8.98%
4 Healthcare 6.75%
5 Financials 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN icon
326
Dyne Therapeutics
DYN
$4.68B
$279K 0.01%
11,848
+1,249
+12% +$36.9K
NET icon
327
Cloudflare
NET
$107B
$277K 0.01%
+2,569
New +$251K
AMT icon
328
American Tower
AMT
$82.1B
$276K 0.01%
1,505
+481
+47% +$99.7K
SCHW
329
Charles Schwab
SCHW
$191B
$274K 0.01%
+3,700
New +$277K
EPAM icon
330
EPAM Systems
EPAM
$5.92B
$273K 0.01%
+1,166
New +$259K
CLDX icon
331
Celldex Therapeutics
CLDX
$3.07B
$273K 0.01%
+10,785
New +$293K
DE icon
332
Deere & Co
DE
$170B
$267K 0.01%
+630
New +$265K
VERA icon
333
Vera Therapeutics
VERA
$2.46B
$262K 0.01%
6,203
+1,130
+22% +$50K
MRSH
334
Marsh
MRSH
$91.9B
$258K 0.01%
+1,216
New +$270K
CB icon
335
Chubb
CB
$131B
$256K 0.01%
+928
New +$264K
LMT icon
336
Lockheed Martin
LMT
$130B
$254K 0.01%
+522
New +$285K
VCYT icon
337
Veracyte
VCYT
$3.48B
$253K 0.01%
+6,392
New +$242K
JNPR
338
DELISTED
Juniper Networks
JNPR
$251K 0.01%
+6,703
New +$254K
PTCT icon
339
PTC Therapeutics
PTCT
$5.85B
$249K 0.01%
5,520
-986
-15% -$42.2K
KKR icon
340
KKR & Co
KKR
$97.6B
$247K 0.01%
+1,671
New +$245K
PLD icon
341
Prologis
PLD
$134B
$242K 0.01%
+2,293
New +$264K
EWJ icon
342
iShares MSCI Japan ETF
EWJ
$22.7B
$242K 0.01%
3,602
-2,419
-40% -$167K
SHW icon
343
Sherwin-Williams
SHW
$83.7B
$242K 0.01%
711
+72
+11% +$26.9K
SRRK icon
344
Scholar Rock
SRRK
$7.04B
$239K 0.01%
+5,524
New +$180K
VRDN icon
345
Viridian Therapeutics
VRDN
$2.61B
$235K 0.01%
+12,236
New +$266K
UPS icon
346
United Parcel Service
UPS
$89.6B
$228K 0.01%
+1,810
New +$238K
DVAX
347
DELISTED
Dynavax Technologies
DVAX
$225K 0.01%
17,627
+771
+5% +$9.33K
SO icon
348
Southern Company
SO
$102B
$223K 0.01%
+2,712
New +$238K
FOLD
349
DELISTED
Amicus Therapeutics
FOLD
$223K 0.01%
23,695
-2,472
-9% -$25.7K
NKE icon
350
Nike
NKE
$58.7B
$223K 0.01%
2,947
-5,483
-65% -$431K

Similar funds

E Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, E Fund Management held 416 positions worth $1.99B, up 2.4% from $1.95B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

E Fund Management deployed $213M of net new capital in Q4 2024, opening 63 new positions and adding to 249 existing holdings. Its largest new stake was Yum China: 222,743 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Pinduoduo, an estimated $45M trimmed.

  • E Fund Management's largest Q4 2024 buy was Yum China: 222,743 shares worth $10.7M.
  • E Fund Management added most to Apple in Q4 2024, an estimated $39.6M increase.
  • E Fund Management's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $45M.
  • E Fund Management fully exited Lufax Holding in Q4 2024, selling an estimated $3.9M.
  • E Fund Management's ten largest holdings make up 56% of its $1.99B portfolio in Q4 2024.
  • E Fund Management opened 63 new positions and closed 21 in Q4 2024.
  • E Fund Management's portfolio value rose 2.4% quarter-over-quarter to $1.99B.

Based on E Fund Management's 13F filing for Q4 2024, filed 7 Feb 2025.